izpis_h1_title_alt

Natural and synthetic derivatives of hydroxycinnamic acid modulating the pathological transformation of amyloidogenic proteins
ID Muronetz, Vladimir I. (Author), ID Barinova, Kseniya (Author), ID Kudryavtseva, Sofia (Author), ID Medvedeva, Maria (Author), ID Melnikova, Aleksandra (Author), ID Sevostyanova, Irina (Author), ID Semenyuk, Pavel (Author), ID Stroylova, Yulia (Author), ID Sova, Matej (Author)

.pdfPDF - Presentation file, Download (4,40 MB)
MD5: 388B43E35957F037B908D597F1476820
URLURL - Source URL, Visit https://www.mdpi.com/1420-3049/25/20/4647 This link opens in a new window

Abstract
This review presents the main properties of hydroxycinnamic acid (HCA) derivatives and their potential application as agents for the prevention and treatment of neurodegenerative diseases. It is partially focused on the successful use of these compounds as inhibitors of amyloidogenic transformation of proteins. Firstly, the prerequisites for the emergence of interest in HCA derivatives, including natural compounds, are described. A separate section is devoted to synthesis and properties of HCA derivatives. Then, the results of molecular modeling of HCA derivatives with prion protein as well as with α-synuclein fibrils are summarized, followed by detailed analysis of the experiments on the effect of natural and synthetic HCA derivatives, as well as structurally similar phenylacetic and benzoic acid derivatives, on the pathological transformation of prion protein and α-synuclein. The ability of HCA derivatives to prevent amyloid transformation of some amyloidogenic proteins, and their presence not only in food products but also as natural metabolites in human blood and tissues, makes them promising for the prevention and treatment of neurodegenerative diseases of amyloid nature.

Language:English
Keywords:neurodegenerative diseases, curcumin, derivatives of hydroxycinnamic acid, amyloid, α-synuclein, prion protein, amyloid fibrils, prevention of amyloid transformation, Parkinson's disease
Work type:Article (dk_c)
Typology:1.02 - Review Article
Organization:FFA - Faculty of Pharmacy
Year:2020
Publication status in journal:Published
Article version:Publisher's version of article
Number of pages:28 str.
Numbering:Vol. 25, iss. 20, art. 4647
UDC:616.858+616.831-003.8
ISSN on article:1420-3049
DOI:10.3390/molecules25204647 This link opens in a new window
COBISS.SI-ID:32284931 This link opens in a new window
Publication date in RUL:13.01.2022
Views:84
Downloads:42
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Share:AddThis
AddThis uses cookies that require your consent. Edit consent...

Record is a part of a journal

Title:Molecules
Shortened title:Molecules
Publisher:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:12.10.2020

Secondary language

Language:Slovenian
Keywords:kurkumin, hidroksicinamska kislina, prion protein, amiloidna transformacija, Parkinsonova bolezen, nevrodegenerativne bolezni

Document is financed by a project

Funder:Drugi - Drug financer ali več financerjev
Funding Programme:Russian Foundation for Basic Research
izpis_stevilka_projekta:19-34-80004

Funder:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije (ARRS)
izpis_stevilka_projekta:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije (ARRS)
izpis_stevilka_projekta:BI-RU/19-20-040

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back